NeuroRehabilitation 21: 23–28 Zolpidem is an omega-1-specific indirect γ-aminobutyric acid (GABA) agonist used to treat insomnia; this drug has also previously been reported to improve the ...

Until the gender differences are more fully elucidated, healthcare professionals should caution patients, particularly women and the elderly, to use the lowest effective dose of zolpidem ...

Zolpidem tartrate 1.75mg, 3.5mg. Zolpidem interacts with gamma-aminobutyric acid-benzodiazepine (GABA-BZ) receptor complex and shares some of the pharmacological properties of benzodiazepines.

Objective and Design: This open, non-comparative, multicentre study was designed to evaluate zolpidem consumption and evolution of its use for the treatment of insomnia on an 'as-needed' basis ...

The Food and Drug Administration (FDA) has approved a handful of sleep medications that can be alternatives to Ambien (zolpidem). Hetlioz (tasimelteon), Neupro (rotigotine transdermal system), and ...

A study published this week suggests that a common sleeping medication, zolpidem, may disrupt the brain’s ability to “cleanse” itself during sleep, potentially raising the risk of Alzheimer ...

A study on zolpidem, a popular sleep aid, suggests it may interfere with the brain's glymphatic system, potentially impacting brain health.

Drugs like the main ingredient in Ambien, zolpidem, suppresses a system designed to clear protein waste from the brain during dreamless sleep, a mouse study published Jan. 8 in the journal Cell shows.